Search research articles
Contact Us
Filters
Showing results (611-620 of 688) with videos related to
Page
of 69
Sort By:
Cancer Medicine
|
July 18, 2022
CINSARC in high-risk soft tissue sarcoma patients treated with neoadjuvant chemotherapy: Results from the ISG-STS 1001 study
Anna Maria Frezza, Silvia Stacchiotti, Frederic Chibon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 14, 2016
Short, full-dose adjuvant chemotherapy (CT) in high-risk adult soft tissue sarcomas (STS): long-term follow-up of a randomized clinical trial from the Italian Sarcoma Group and the Spanish Sarcoma Group
A Gronchi, S Stacchiotti, P Verderio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 7, 2025
Trabectedin-olaparib combination or trabectedin in advanced soft tissue sarcomas after failure of anthracycline-based treatment (TOMAS2): a randomized phase II study from the Italian Sarcoma Group
L D'Ambrosio, A Merlini, A Brunello, et al.
Journal of Clinical Medicine
|
April 3, 2021
Post-Transplant Cyclophosphamide and Tacrolimus-Mycophenolate Mofetil Combination Governs GVHD and Immunosuppression Need, Reducing Late Toxicities in Allogeneic Peripheral Blood Hematopoietic Cell Transplantation from HLA-Matched Donors
Fabrizio Carnevale-Schianca, Daniela Caravelli, Susanna Gallo, et al.
Cancers
|
July 2, 2021
Whole Lung Irradiation after High-Dose Busulfan/Melphalan in Ewing Sarcoma with Lung Metastases: An Italian Sarcoma Group and Associazione Italiana Ematologia Oncologia Pediatrica Joint Study
Massimo E Abate, Silvia Cammelli, Letizia Ronchi, et al.
Frontiers in Oncology
|
December 26, 2022
Transcription regulators and ultra-rare and other rare translocation-related sarcomas treated with trabectedin: A proof of principle from a <i>post-hoc</i> analysis
Emanuela Palmerini, Roberta Sanfilippo, Giovanni Grignani, et al.
Ebiomedicine
|
July 17, 2024
Spatial distribution of tumour immune infiltrate predicts outcomes of patients with high-risk soft tissue sarcomas after neoadjuvant chemotherapy
Sandro Pasquali, Viviana Vallacchi, Luca Lalli, et al.
Cancer
|
November 18, 2020
Defining the role of neoadjuvant systemic therapy in high-risk retroperitoneal sarcoma: A multi-institutional study from the Transatlantic Australasian Retroperitoneal Sarcoma Working Group
William W Tseng, Francesco Barretta, Lorenzo Conti, et al.
Annals of Surgical Oncology
|
March 21, 2022
Correction to: Analysis of Differentiation Changes and Outcomes at Time of First Recurrence of Retroperitoneal Liposarcoma by Transatlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG)
Carolyn Nessim, Chandrajit P Raut, Dario Callegaro, et al.
Annals of Surgical Oncology
|
March 21, 2022
Correction to: Postoperative Morbidity After Resection of Recurrent Retroperitoneal Sarcoma: A Report from the Transatlantic Australasian RPS Working Group (TARPSWG)
Carolyn Nessim, Chandrajit P Raut, Dario Callegaro, et al.
Page
of 69
Search research articles
Search
Showing results (611-620 of 688) with videos related to
Sort By:
Page
of 69
Cancer Medicine
|
July 18, 2022
CINSARC in high-risk soft tissue sarcoma patients treated with neoadjuvant chemotherapy: Results from the ISG-STS 1001 study
Anna Maria Frezza, Silvia Stacchiotti, Frederic Chibon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 14, 2016
Short, full-dose adjuvant chemotherapy (CT) in high-risk adult soft tissue sarcomas (STS): long-term follow-up of a randomized clinical trial from the Italian Sarcoma Group and the Spanish Sarcoma Group
A Gronchi, S Stacchiotti, P Verderio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 7, 2025
Trabectedin-olaparib combination or trabectedin in advanced soft tissue sarcomas after failure of anthracycline-based treatment (TOMAS2): a randomized phase II study from the Italian Sarcoma Group
L D'Ambrosio, A Merlini, A Brunello, et al.
Journal of Clinical Medicine
|
April 3, 2021
Post-Transplant Cyclophosphamide and Tacrolimus-Mycophenolate Mofetil Combination Governs GVHD and Immunosuppression Need, Reducing Late Toxicities in Allogeneic Peripheral Blood Hematopoietic Cell Transplantation from HLA-Matched Donors
Fabrizio Carnevale-Schianca, Daniela Caravelli, Susanna Gallo, et al.
Cancers
|
July 2, 2021
Whole Lung Irradiation after High-Dose Busulfan/Melphalan in Ewing Sarcoma with Lung Metastases: An Italian Sarcoma Group and Associazione Italiana Ematologia Oncologia Pediatrica Joint Study
Massimo E Abate, Silvia Cammelli, Letizia Ronchi, et al.
Frontiers in Oncology
|
December 26, 2022
Transcription regulators and ultra-rare and other rare translocation-related sarcomas treated with trabectedin: A proof of principle from a <i>post-hoc</i> analysis
Emanuela Palmerini, Roberta Sanfilippo, Giovanni Grignani, et al.
Ebiomedicine
|
July 17, 2024
Spatial distribution of tumour immune infiltrate predicts outcomes of patients with high-risk soft tissue sarcomas after neoadjuvant chemotherapy
Sandro Pasquali, Viviana Vallacchi, Luca Lalli, et al.
Cancer
|
November 18, 2020
Defining the role of neoadjuvant systemic therapy in high-risk retroperitoneal sarcoma: A multi-institutional study from the Transatlantic Australasian Retroperitoneal Sarcoma Working Group
William W Tseng, Francesco Barretta, Lorenzo Conti, et al.
Annals of Surgical Oncology
|
March 21, 2022
Correction to: Analysis of Differentiation Changes and Outcomes at Time of First Recurrence of Retroperitoneal Liposarcoma by Transatlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG)
Carolyn Nessim, Chandrajit P Raut, Dario Callegaro, et al.
Annals of Surgical Oncology
|
March 21, 2022
Correction to: Postoperative Morbidity After Resection of Recurrent Retroperitoneal Sarcoma: A Report from the Transatlantic Australasian RPS Working Group (TARPSWG)
Carolyn Nessim, Chandrajit P Raut, Dario Callegaro, et al.
Page
of 69